Kappac Pharma (Delisted) share news and announcements
BSE: 506938Pharmaceuticals & Biotechnology
Last traded ₹112.85 on 6 Jan 2015
Delisted on 23 Nov 2023.
Kappac Pharma share news and announcements
199 announcements, routine notices left out, newest first. Page 2 of 4.
May 2019
3 May · Compliances-Certificate under Reg. 54 (5) of SEBI (DP) Regulations, 1996
Apr 2019
22 Apr · Submission Of Certificate By PCS Under Regulation 40(9) Of The SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015
11 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Of The Financial Year Ended March 31, 2019
5 Apr · Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2019
7 Mar · Meeting
Feb 2019
28 Feb · Board meeting
Meeting on 28 Feb 2019
Jan 2019
24 Jan · Board meeting
Meeting on 1 Feb 2019: quarterly results9 Jan · Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Nov 2018
Oct 2018
26 Oct · Submission Of Certificate Under Regulation 40(9} Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
25 Oct · Compliance Certificate Pursuant To Regulation 7(3) Of The SEDI Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Period From April 1,2018 To September 30, 2018.
16 Oct · Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2018
1 Sep · Meeting
Jul 2018
5 Jul · Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
May 2018
Apr 2018
28 Apr · Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
25 Apr · Compliance Certificate For The Half Year Ended March,31 2018.
15 Apr · Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Feb 2018
Jan 2018
3 Jan · Statement Of Investor Complaints For The Quarter Ended December,2017
Nov 2017
Oct 2017
31 Oct · Submission Of Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirement) Regulation, 2015 For The Half Year Ended On 30.09.2017
18 Oct · Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Financial Year Ended September 30, 2017.
13 Oct · Statement Of Investor Complaints For Second Quarter Ended 30.09.2017
Sep 2017
19 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2017
Jul 2017
5 Jul · Statement On Investor Complaints For Fourth Quarter Ended 30.06.2017
May 2017
Apr 2017
22 Apr · Submission Of Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015 For The Half Year Ended March, 2017